Print this page
-
Needs Survey for Childhood, Adolescent, Young Adults (CAYA) Cancer Survivors, Their Siblings, and Parents/Caregivers.
Protocol: 132213Principal Investigator:
- Katie Devine (Rutgers University)
Applicable Disease Sites: Leukemia, not otherwise specified
Brain and Nervous System
Any Site
Non-Hodgkin's Lymphoma
Leukemia, other
Hodgkin's Lymphoma
Bones and Joints -
A Phase 2 Study of Dabrafenib with Trametinib after Local Irradiation in Newly-Diagnosed BRAFV600-Mutant High-Grade Glioma (HGG).
Protocol: 112302Principal Investigator:
- Teena Bhatla (Newark Beth Israel Medical Center)
Applicable Disease Sites: Brain and Nervous System -
Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients with Methylated MGMT Promoter Glioblastoma.
Protocol: 142202Principal Investigator:
- Andrew Brown MD (Cooperman Barnabas, Livingston)
Applicable Disease Sites: Brain and Nervous System -
A Phase 1/2 Trial of Selinexor (KPT-330) and Radiation Therapy in Newly-Diagnosed Pediatric Diffuse Intrinsic Pontine Glioma (DIPG) and High-Grade Glioma (HGG).
Protocol: 112203Principal Investigator:
- Scott Moerdler M.D. (Rutgers University)
Applicable Disease Sites: Brain and Nervous System -
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients.
Protocol: 111708Principal Investigator:
- Richard Drachtman M.D. (Rutgers University)
Applicable Disease Sites: Brain and Nervous System -
Phase II Trial of BRAF/MEK Inhibitors in Papillary Craniopharyngiomas.
Protocol: 141905Principal Investigator:
- Pankaj Agarwalla (Rutgers University)
Applicable Disease Sites: Brain and Nervous System
- 1
- 2